• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于(E)-尿刊酸,简便高效地合成了一系列 N-苄基和 N-联苯甲基取代的咪唑衍生物,作为血管紧张素 II AT1 受体阻断剂。

Facile and efficient syntheses of a series of N-benzyl and N-biphenylmethyl substituted imidazole derivatives based on (E)-urocanic acid, as angiotensin II AT1 receptor blockers.

机构信息

Department of Chemistry, University of Patras, Patras 26500, Greece.

出版信息

Molecules. 2013 Jun 27;18(7):7510-32. doi: 10.3390/molecules18077510.

DOI:10.3390/molecules18077510
PMID:23807577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6270370/
Abstract

In the present work, a facile and efficient route for the synthesis of a series of N-substituted imidazole derivatives is described. Docking studies have revealed that N-substituted imidazole derivatives based on (E)-urocanic acid may be potential antihypertensive leads. Therefore, new AT1 receptor blockers bearing either the benzyl or the biphenylmethyl moiety at the N-1 or N-3 position, either the (E)-acrylate or the propanoate fragment and their related acids at the C-4 position as well as a halogen atom at the C-5 position of the imidazole ring, were synthesized. The newly synthesized analogues were evaluated for binding to human AT1 receptor. The biological results showed that this class of molecules possesses moderate or no activity, thus not always confirming high docking scores. Nonetheless, important conclusions can be derived for their molecular basis of their mode of action and help medicinal chemists to design and synthesize more potent ones. An aliphatic group as in losartan seems to be important for enhancing binding affinity and activity.

摘要

在本工作中,描述了一种简便有效的合成一系列 N-取代咪唑衍生物的方法。对接研究表明,基于(E)-尿刊酸的 N-取代咪唑衍生物可能是潜在的抗高血压先导化合物。因此,合成了一系列在 N-1 或 N-3 位带有苄基或联苯甲基部分、在 C-4 位带有 (E)-丙烯酸盐或丙酸盐片段及其相关酸以及咪唑环的 C-5 位带有卤素原子的新型 AT1 受体阻滞剂。新合成的类似物被评估对人 AT1 受体的结合活性。生物实验结果表明,该类分子具有中等或无活性,因此并不总是与高对接评分一致。尽管如此,仍可以从其作用模式的分子基础中得出重要结论,并帮助药物化学家设计和合成更有效的化合物。类似洛沙坦中的脂肪族基团对于增强结合亲和力和活性似乎很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/fb164cc57ab0/molecules-18-07510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/9c1b3ccea9c3/molecules-18-07510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/8b526f9bb3b6/molecules-18-07510-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/f7df74a0cdf3/molecules-18-07510-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/c8c0ac0e9eb3/molecules-18-07510-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/5d0d9a00d71e/molecules-18-07510-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/fb164cc57ab0/molecules-18-07510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/9c1b3ccea9c3/molecules-18-07510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/8b526f9bb3b6/molecules-18-07510-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/f7df74a0cdf3/molecules-18-07510-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/c8c0ac0e9eb3/molecules-18-07510-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/5d0d9a00d71e/molecules-18-07510-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f408/6270370/fb164cc57ab0/molecules-18-07510-g002.jpg

相似文献

1
Facile and efficient syntheses of a series of N-benzyl and N-biphenylmethyl substituted imidazole derivatives based on (E)-urocanic acid, as angiotensin II AT1 receptor blockers.基于(E)-尿刊酸,简便高效地合成了一系列 N-苄基和 N-联苯甲基取代的咪唑衍生物,作为血管紧张素 II AT1 受体阻断剂。
Molecules. 2013 Jun 27;18(7):7510-32. doi: 10.3390/molecules18077510.
2
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.新型强效非肽类血管紧张素 II AT1 受体阻滞剂的发现:N-取代 5-丁基咪唑衍生物的简明合成、分子对接研究和生物学评价。
Eur J Med Chem. 2012 Sep;55:358-74. doi: 10.1016/j.ejmech.2012.07.040. Epub 2012 Jul 31.
3
Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers.N,N'-对称双取代丁基咪唑类似物作为新型强效血管紧张素 II 受体阻断剂的合理设计、高效合成及生物评价。
Eur J Med Chem. 2013 Apr;62:352-70. doi: 10.1016/j.ejmech.2012.12.044. Epub 2013 Jan 2.
4
Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.血管紧张素II - AT1受体拮抗剂:取代羧酰胺基苯并咪唑衍生物的设计、合成与评价
Eur J Med Chem. 2008 Sep;43(9):1808-12. doi: 10.1016/j.ejmech.2007.11.008. Epub 2007 Nov 22.
5
Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analogues.新型非肽类抗高血压类似物的合成、结合研究及体内生物学评价
Bioorg Med Chem. 2006 Jul 1;14(13):4353-60. doi: 10.1016/j.bmc.2006.02.044. Epub 2006 Mar 20.
6
Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.嘧啶-4(3H)-酮衍生物的合成及其作为氯沙坦类似物的抗高血压活性,用于新型血管紧张素 II 受体型 1(AT1)拮抗剂。
Bioorg Med Chem Lett. 2012 Feb 15;22(4):1649-54. doi: 10.1016/j.bmcl.2011.12.116. Epub 2012 Jan 2.
7
Selenosartans: novel selenophene analogues of milfasartan and eprosartan.硒沙坦类药物:米尔沙坦和依普罗沙坦的新型硒吩类似物。
Bioorg Med Chem Lett. 2008 Feb 1;18(3):1241-4. doi: 10.1016/j.bmcl.2007.11.136. Epub 2008 Jan 1.
8
Design, synthesis and biological evaluation of AT receptor blockers derived from 6-substituted aminocarbonyl benzimidazoles.设计、合成及生物评价来源于 6-取代氨甲酰基苯并咪唑的 AT 受体阻滞剂。
Eur J Med Chem. 2019 Nov 1;181:111553. doi: 10.1016/j.ejmech.2019.07.056. Epub 2019 Jul 24.
9
Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.新型四唑基和羧基联苯甲基喹唑啉-4-酮衍生物作为血管紧张素II AT1受体拮抗剂的设计与合成
J Med Chem. 2006 Mar 9;49(5):1526-35. doi: 10.1021/jm050232e.
10
Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.基于4-苯基喹啉结构的新型强效AT(1)血管紧张素II受体拮抗剂的设计、合成、结构研究、生物学评价及计算模拟
J Med Chem. 2004 May 6;47(10):2574-86. doi: 10.1021/jm031100t.

引用本文的文献

1
Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.乙酰氨基阿维菌素可减轻血管紧张素 II 收缩作用并与严重急性呼吸综合征冠状病毒 2 的刺突蛋白相互作用。
Biomedicines. 2022 Jul 18;10(7):1731. doi: 10.3390/biomedicines10071731.
2
From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.从血管紧张素 II 到环肽和血管紧张素受体阻滞剂 (ARB):ARB 在 COVID-19 治疗中的观点。
Molecules. 2021 Jan 25;26(3):618. doi: 10.3390/molecules26030618.
3
A Global Review on Short Peptides: Frontiers and Perspectives.

本文引用的文献

1
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.新型强效非肽类血管紧张素 II AT1 受体阻滞剂的发现:N-取代 5-丁基咪唑衍生物的简明合成、分子对接研究和生物学评价。
Eur J Med Chem. 2012 Sep;55:358-74. doi: 10.1016/j.ejmech.2012.07.040. Epub 2012 Jul 31.
2
Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension.奥美沙坦酯:一种用于治疗高血压的新型血管紧张素 II 受体拮抗剂。
Ann Pharmacother. 2011 Dec;45(12):1506-15. doi: 10.1345/aph.1Q468. Epub 2011 Nov 24.
3
短肽的全球研究综述:前沿与展望。
Molecules. 2021 Jan 15;26(2):430. doi: 10.3390/molecules26020430.
4
Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2.与血管紧张素转换酶 2(ACE2)和血管紧张素受体 1 和 2 结合的结构决定因素。
Front Pharmacol. 2015 Jan 30;6:5. doi: 10.3389/fphar.2015.00005. eCollection 2015.
Significance of pigment epithelium-derived factor levels with angiotensin II type 1 receptor blockers in patients with successful coronary stent implantation.
成功接受冠状动脉支架植入术患者的色素上皮衍生因子水平与血管紧张素 II 型 1 受体阻滞剂的相关性。
J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):320-5. doi: 10.1177/1470320310391921. Epub 2011 Feb 17.
4
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.血管紧张素 II 受体 1 型(AT1)选择性非肽类拮抗剂——一个视角。
Bioorg Med Chem. 2010 Dec 15;18(24):8418-56. doi: 10.1016/j.bmc.2010.10.043. Epub 2010 Nov 9.
5
An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT(1) angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies.一种合理设计的 1,5 取代咪唑 AT(1)血管紧张素 II 受体拮抗剂的高效合成:氯沙坦咪唑药效团基团的重新定位保留了高受体亲和力,并证实了对接研究。
J Comput Aided Mol Des. 2010 Sep;24(9):749-58. doi: 10.1007/s10822-010-9371-3. Epub 2010 Jul 10.
6
Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation.基于尿刊酸的非肽类血管紧张素 II AT1 受体拮抗剂:合理设计、合成与生物评价。
Amino Acids. 2011 Feb;40(2):411-20. doi: 10.1007/s00726-010-0651-y. Epub 2010 Jul 6.
7
Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists.新型血管紧张素 II 受体拮抗剂 5-氨磺酰基苯并咪唑衍生物的设计、合成与评价
Bioorg Med Chem. 2008 Dec 15;16(24):10210-5. doi: 10.1016/j.bmc.2008.10.056. Epub 2008 Oct 29.
8
Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.
J Med Chem. 2008 Apr 10;51(7):2137-46. doi: 10.1021/jm7011563. Epub 2008 Mar 5.
9
Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.
Bioorg Med Chem Lett. 2007 May 15;17(10):2921-6. doi: 10.1016/j.bmcl.2007.02.042. Epub 2007 Feb 20.
10
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.超高精度滑动:结合蛋白质-配体复合物疏水包封模型的对接与评分
J Med Chem. 2006 Oct 19;49(21):6177-96. doi: 10.1021/jm051256o.